SCHEMBL5136459

SCHEMBL5136459

CCCCCC(Cl)(Br)Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5704637 0.80 TSHR (0.44)
SCHEMBL10577979 0.78
SCHEMBL254258 0.76 GGPS1 (0.41)
SCHEMBL6267797 0.75
SCHEMBL8601485 0.75 TSHR (0.44)
SCHEMBL876998 0.75 TSHR (0.44)
SCHEMBL968652 0.75
Hexane SCHEMBL6072655 0.73 TSHR (0.58)
Hexane SCHEMBL268437 0.73
SCHEMBL665460 0.73 TSHR (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7462752-B2 Process to convert linear alkanes into alpha olefins SHELL OIL COMPANY (US) 2008-12-09 US disclosed
US-7091387-B2 Process to convert alkanes into primary alcohols SHELL OIL COMPANY (US) 2006-08-15 US disclosed
WO-2005110953-A1 DERIVATIVES OF ALCOHOLS AND OLEFINS SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) 2005-11-24 WO disclosed
WO-2005105715-A1 PROCESS TO CONVERT ALKANES INTO PRIMARY ALCOHOLS SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) 2005-11-10 WO disclosed
WO-2005105709-A1 PROCESS TO CONVERT LINEAR ALKANES INTO ALPHA OLEFINS SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) 2005-11-10 WO disclosed
US-20050245772-A1 Derivatives of alcohols and olefins SHELL OIL COMPANY 2005-11-03 US disclosed
US-20050245777-A1 Process to convert linear alkanes into alpha olefins SHELL OIL COMPANY 2005-11-03 US disclosed
US-20050245771-A1 Process to convert alkanes into primary alcohols SHELL OIL COMPANY 2005-11-03 US disclosed